查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596742

幹細胞檢測市場：按產品、檢測和應用分類 - 2025-2030 年全球預測

Stem Cell Assays Market by Product (Instruments, Reagents & Kits), Assay (Apoptosis Assays, Cell Identification Assays, Isolation & Purification Assays), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

幹細胞檢測市場2023年估值為27.5億美元，預計到2024年將達到33.7億美元，複合年成長率為22.65%，預計到2030年將達到115.2億美元。

幹細胞檢測是生物技術和醫學研究的重要工具，主要用於評估幹細胞的增殖、分化和遺傳穩定性等特性。人們對幹細胞在再生醫學、藥物發現和發育生物學中的潛力的日益了解凸顯了它們的需求。幹細胞可應用於藥物開發、毒性測試、癌症研究和再生醫學，最終用途主要是製藥公司、生技公司和學術研究機構。主要成長動力包括個人化醫療需求的增加、自動化程度的提高以及人工智慧技術的快速整合以實現高通量篩檢過程。最近的技術進步和 3D 細胞培養技術的出現降低了檢測成本，提供了利潤豐厚的機會。然而，該市場也面臨重大障礙，例如嚴格的監管環境、幹細胞研究的倫理問題以及與先進檢測技術相關的高成本，可能阻礙廣泛採用。為了發展您的業務，您應該專注於應對這些挑戰的創新，例如開發具有成本效益的檢測解決方案和提供藥物反應高預測準確性的人性化模型。此外，協作研究和開發工作可以幫助自動化和提高檢測靈敏度。在持續的科學突破和不斷變化的監管政策的推動下，市場競爭激烈且快速發展。為了保持領先地位，我們必須關注新興趨勢，例如機器學習和幹細胞檢測的整合以增強預測分析。公司必須投資強大的研發開發平臺，利用跨產業協作，並維持適應性策略以應對技術進步和監管變化。這些努力將有助於充分利用成長潛力，並在這個快速成長的行業中建立競爭優勢。

主要市場統計
基準年[2023] 27.5億美元
預測年份 [2024] 33.7億美元
預測年份 [2030] 115.2億美元
複合年成長率（%） 22.65%

市場動態：快速發展的幹細胞檢測市場的關鍵市場洞察

供需的動態交互作用正在改變幹細胞檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 人們越來越認知到幹細胞的治療益處
    • 全球幹細胞研究支出增加
    • 藥物發現中對細胞分析的需求不斷成長
  • 市場限制因素
    • 胚胎幹細胞研究的挑戰
  • 市場機會
    • 支持幹細胞臨床研究的資金和津貼的可用性
    • 新型幹細胞分析系統的開發與行銷
  • 市場挑戰
    • 新興國家缺乏幹細胞研究基礎設施
    • 缺乏訓練有素、技術熟練的專業人員

波特五力：駕馭幹細胞檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解幹細胞檢測市場的外部影響

外部宏觀環境因素在塑造幹細胞檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解幹細胞偵測市場的競爭格局

幹細胞檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質幹細胞檢測市場供應商績效評估

FPNV定位矩陣是評估幹細胞檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了幹細胞檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，幹細胞檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人們越來越認知到幹細胞的治療益處
      • 世界各地對幹細胞研究的資助增加
      • 藥物發現中對細胞分析的需求增加
    • 抑制因素
      • 胚胎幹細胞研究的問題
    • 機會
      • 支持幹細胞臨床研究的資金和津貼的可用性
      • 新型幹細胞分析系統的開發與發布
    • 任務
      • 新興國家缺乏幹細胞研究基礎設施
      • 缺乏訓練有素、技術熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章幹細胞檢測市場：依產品

  • 裝置
  • 試劑和套件

第7章幹細胞檢測市場分析

  • 細胞凋亡檢測
  • 細胞鑑定試驗
  • 分離和精製分析
  • 能源或細胞毒性測試

第8章幹細胞檢測市場：依應用分類

  • 臨床調查
  • 藥物發現與開發
  • 再生醫學和治療

第9章美洲幹細胞檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太幹細胞檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的幹細胞檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Astellas Pharma Inc.
  • Bio-Rad Laboratories, Inc.
  • BioTime, Inc.
  • Biovault Family Ltd.
  • Caladrius Biosciences, Inc.
  • Celgene Corporation
  • Cell Biolabs, Inc.
  • HemoGenix, Inc.
  • Mesoblast Ltd
  • Miltenyi Biotec GmbH
  • Opexa Therapeutics, Inc.
  • PerkinElmer, Inc.
  • Pluristem Therapeutics Inc
  • Precious Cells International Ltd
  • ReNeuron Group PLC
Product Code: MRR-0D217D5AF84D

The Stem Cell Assays Market was valued at USD 2.75 billion in 2023, expected to reach USD 3.37 billion in 2024, and is projected to grow at a CAGR of 22.65%, to USD 11.52 billion by 2030.

Stem cell assays are pivotal tools in biotechnology and medical research, primarily used to assess the properties of stem cells, including their proliferation, differentiation, and genetic stability. The increased understanding of these cells' potential in regenerative medicine, drug discovery, and developmental biology underscores their necessity. They find applications across drug development, toxicity testing, cancer research, and regenerative medicine, with end-use predominantly in pharmaceutical companies, biotechnology firms, and academic research institutes. Key growth drivers include the escalating demand for personalized medicine, ongoing advancements in automation, and the rapid integration of AI technologies enabling high-throughput screening processes. Recent technological improvements reducing assay costs and the emergence of 3D cell culture techniques offer lucrative opportunities. However, the market also faces significant hurdles, such as the stringent regulatory landscape, ethical concerns surrounding stem cell research, and the high cost associated with advanced assay technologies, potentially hindering widespread adoption. For business growth, organizations should focus on innovations addressing these challenges, such as developing cost-effective assay solutions or exploring more humanized models that offer high predictive accuracy for drug responses. Engaging in collaborative research and development initiatives can also spur advancements in automating and improving assay sensitivity. The nature of the market is highly competitive and rapidly evolving, driven by continuous scientific breakthroughs and evolving regulatory policies. Staying ahead necessitates a keen focus on emerging trends such as the integration of machine learning with stem cell assays to enhance predictive analytics. Firms must invest in robust R&D pipelines, leverage cross-industry collaborations, and maintain adaptive strategies to keep pace with technological advancements and regulatory changes. These endeavors will help harness potential growth and carve a competitive edge in this burgeoning field.

KEY MARKET STATISTICS
Base Year [2023] USD 2.75 billion
Estimated Year [2024] USD 3.37 billion
Forecast Year [2030] USD 11.52 billion
CAGR (%) 22.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stem Cell Assays Market

The Stem Cell Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness about therapeutic potency of stem cells
    • Rising funding for stem cell research globally
    • Growing demand for cell-based assays in drug discovery
  • Market Restraints
    • Issues in embryonic stem cell research
  • Market Opportunities
    • Availability of funding and grants to support the clinical research on stem cells
    • Development and launch of new stem cell analysis systems
  • Market Challenges
    • Lack of infrastructure for stem cell research in emerging economies
    • Dearth of trained and skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Stem Cell Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stem Cell Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stem Cell Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stem Cell Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stem Cell Assays Market

A detailed market share analysis in the Stem Cell Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stem Cell Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stem Cell Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stem Cell Assays Market

A strategic analysis of the Stem Cell Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stem Cell Assays Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BioTime, Inc., Biovault Family Ltd., Caladrius Biosciences, Inc., Celgene Corporation, Cell Biolabs, Inc., HemoGenix, Inc., Mesoblast Ltd, Miltenyi Biotec GmbH, Opexa Therapeutics, Inc., PerkinElmer, Inc., Pluristem Therapeutics Inc, Precious Cells International Ltd, and ReNeuron Group PLC.

Market Segmentation & Coverage

This research report categorizes the Stem Cell Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments and Reagents & Kits.
  • Based on Assay, market is studied across Apoptosis Assays, Cell Identification Assays, Isolation & Purification Assays, and Viability or Cytotoxicity Assays.
  • Based on Application, market is studied across Clinical Research, Drug Discovery & Development, and Regenerative Medicine & Therapy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness about therapeutic potency of stem cells
      • 5.1.1.2. Rising funding for stem cell research globally
      • 5.1.1.3. Growing demand for cell-based assays in drug discovery
    • 5.1.2. Restraints
      • 5.1.2.1. Issues in embryonic stem cell research
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of funding and grants to support the clinical research on stem cells
      • 5.1.3.2. Development and launch of new stem cell analysis systems
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of infrastructure for stem cell research in emerging economies
      • 5.1.4.2. Dearth of trained and skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stem Cell Assays Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits

7. Stem Cell Assays Market, by Assay

  • 7.1. Introduction
  • 7.2. Apoptosis Assays
  • 7.3. Cell Identification Assays
  • 7.4. Isolation & Purification Assays
  • 7.5. Viability or Cytotoxicity Assays

8. Stem Cell Assays Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Research
  • 8.3. Drug Discovery & Development
  • 8.4. Regenerative Medicine & Therapy

9. Americas Stem Cell Assays Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Stem Cell Assays Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Stem Cell Assays Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Astellas Pharma Inc.
  • 2. Bio-Rad Laboratories, Inc.
  • 3. BioTime, Inc.
  • 4. Biovault Family Ltd.
  • 5. Caladrius Biosciences, Inc.
  • 6. Celgene Corporation
  • 7. Cell Biolabs, Inc.
  • 8. HemoGenix, Inc.
  • 9. Mesoblast Ltd
  • 10. Miltenyi Biotec GmbH
  • 11. Opexa Therapeutics, Inc.
  • 12. PerkinElmer, Inc.
  • 13. Pluristem Therapeutics Inc
  • 14. Precious Cells International Ltd
  • 15. ReNeuron Group PLC

LIST OF FIGURES

  • FIGURE 1. STEM CELL ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. STEM CELL ASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEM CELL ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. STEM CELL ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. STEM CELL ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEM CELL ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEM CELL ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STEM CELL ASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY APOPTOSIS ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY CELL IDENTIFICATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY ISOLATION & PURIFICATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY VIABILITY OR CYTOTOXICITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY REGENERATIVE MEDICINE & THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. STEM CELL ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. STEM CELL ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023